Avid Bioservices Inc (CDMO)

[entdoc]

rats and mice and preclinical data...
from the point of view of a doctor who treats cancer, and has spent time in research labs, this Brekken study of lung cancer in mice treated with irradiation and Bavi with 100% survival and 40% cure is VERY compelling when extrapolating to humans IN LIGHT OF the mechanism of action which has been so clearly and elegantly demonstrated...where?...not in humans, but in mice. All effort must now move in the direction of the greatest good for the greatest number. The price of the stock will take off when the abbreviated and accelerated irradiation + Bavitrials are encouraged and green-lighted by the FDA, and as suspense begins to build over the results of the trial in humans. Take a clip from the ImCL Erbitux playbook. This could be the breakthrough we have been waiting for. By the time results are in on the Bavi + irradiation trial in humans the price will already be in the $35+ range.
PS: the alias2002, thanks for the ecomium,eulogy, panegyric, paean, accolade, tribute, and/or testimonial. One of the funnier posts I've read.